bioRxiv Science⌕ Search

Biology subjects

Bogati, B.

Publications and source records attributed to Bogati, B..

3 recordsLinked to original sources

Rapid Bacterial Identification and Antibiotic Susceptibility Testing through Interferometry-based Surface Topography Measurement

Scientists have long classified organisms based on shared morphological characteristics. However, modern taxonomy, particularly for bacteria, is largely defined at the genetic level. Yet the information encoded in genetics propagates through many levels of biological organization: genes determine patterns of gene expression and protein production which, in turn, influence cellular physiology and behavior which, in turn, influence the collective morphology of growing populations. It is unclear how far up this hierarchy that the lower level taxonomic information remains preserved. Here, we show that bacterial genera can be identified from differences in the three-dimensional topographies of their growing populations. Using coherence-scanning white-light interferometry (WLI), which is capable of nanometer-resolution, we measure bacterial population topographies of 77 different clinical isolates representing four different genera. We then extract ten biophysically relevant features describing their surface structure. Using a simple machine-learning classifier, these topographic features identified bacterial genus with 97% accuracy, demonstrating that genus-level information remains present at the scale of population morphology. We hypothesize that these topographic "fingerprints" arise because differences in the underlying biophysics of bacterial growth propagate upward into measurable differences in population structure. To test this hypothesis, we performed biophysical simulations of bacterial population growth and applied our experimentally trained classifier directly to the resulting simulated topographies. By systematically modifying simulation parameters, we determined which changes were necessary to generate topographies classified as each of the experimentally observed genera. We find that a relatively small number of differences in cellular growth, cell-surface interactions, and initial conditions are sufficient to recreate the genus-associated differences observed experimentally, and we then show that using the topographic features from the simulations we can recover the underlying parameters used to simulate the topographies. Together, these results show that differences in lower-level bacterial behavior can propagate into distinct population-scale morphologies, and that taxonomic information can remain recoverable far above the molecular scale at which bacterial identity is conventionally defined.

biophysics↗

Sulbactam-durlobactam susceptibility among cefiderocol heteroresistant Acinetobacter

The ATTACK clinical trial for treatment of carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRAB) isolates determined treatment with sulbactam-durlobactam to be efficacious and safe. However, other newly introduced {beta}-lactam antibiotics, including the novel cephalosporin cefiderocol, have been compromised upon clinical introduction by a type of antibiotic resistance called heteroresistance, in which only a small subpopulation of total cells exhibit phenotypic resistance. Therefore, we sought to test for sulbactam-durlobactam heteroresistance, as well as whether sulbactam-durlobactam was effective against cefiderocol heteroresistant CRAB isolates. We did not observe heteroresistance (or conventional resistance) to sulbactam-durlobactam among the 107 carbapenem-resistant Acinetobacter isolates tested, consistent with the efficacy of this new antibiotic in the ATTACK trial. Further, sulbactam-durlobactam was active against cefiderocol heteroresistant CRAB, highlighting that this antibiotic may be prioritized in relation to cefiderocol in treating CRAB infections.

microbiology↗

Translocation of gut commensal bacteria to the brain

The gut-brain axis, a bidirectional signaling network between the intestine and the central nervous system, is crucial to the regulation of host physiology and inflammation. Recent advances suggest a strong correlation between gut dysbiosis and neurological diseases, however, relatively little is known about how gut bacteria impact the brain. Here, we reveal that gut commensal bacteria can translocate directly to the brain when mice are fed an altered diet that causes dysbiosis and intestinal permeability, and that this also occurs without diet alteration in distinct murine models of neurological disease. The bacteria were not found in other systemic sites or the blood, but were detected in the vagus nerve. Unilateral cervical vagotomy significantly reduced the number of bacteria in the brain, implicating the vagus nerve as a conduit for translocation. The presence of bacteria in the brain correlated with microglial activation, a marker of neuroinflammation, and with neural protein aggregation, a hallmark of several neurodegenerative diseases. In at least one model, the presence of bacteria in the brain was reversible as a switch from high-fat to standard diet resulted in amelioration of intestinal permeability, led to a gradual loss of detectable bacteria in the brain, and reduced the number of neural protein aggregates. Further, in murine models of Alzheimers disease, Parkinsons disease, and autism spectrum disorder, we observed gut dysbiosis, gut leakiness, bacterial translocation to the brain, and microglial activation. These data reveal a commensal bacterial translocation axis to the brain in models of diverse neurological diseases.

neuroscience↗